MedPath

Assessing sedo-analgesic effects: A comparative analysis of ketamine vs dexmedetomidine infusion.

Phase 4
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2023/07/055164
Lead Sponsor
Kailash Prasad
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patient of ASA-I & ASA-II physical status.Patient between 18-60 years of age of either gender.Patient with Mallampati Class I-II.Patient posted for upper limb surgery under supraclavicular nerve block.Patient willing to participate

Exclusion Criteria

Patient refusal to participate.

Patients with ASA physical status III and above

Patient aged less than 18 years and more than 60 years

Patient allergic to study drugs.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To access analgesia using VAS score up to 24 hours post operatively. <br/ ><br>Timepoint: 24 hours <br/ ><br> <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
To access peri-operative sedation using modified Ramsay sedation scoring system. <br/ ><br> <br/ ><br>Timepoint: 5 hours
© Copyright 2025. All Rights Reserved by MedPath